Advantages and Pitfalls of Glypican-3 Immunohistochemistry in the Distinction of Hepatocellular Carcinoma and Metastatic Carcinomas

被引：0
|
作者：
Ramachandran, R. [1 ]
Browne, L. W. [1 ]
Kakar, S. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
LABORATORY INVESTIGATION | 2009年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1448
引用
收藏
页码：319A / 320A
页数：2
相关论文
共 50 条
  • [21] Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma
    Chen, Min
    Li, Guohua
    Yan, Jian
    Lu, Xiuzhi
    Cui, Jianwei
    Ni, Zhengxian
    Cheng, Weizhong
    Qian, Gengsun
    Zhang, Jing
    Tu, Hong
    CLINICA CHIMICA ACTA, 2013, 423 : 105 - 111
  • [22] Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
    Allegretta, Mark
    Filmus, Jorge
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (06) : 543 - 548
  • [23] Imaging the expression of glypican-3 in hepatocellular carcinoma by PET
    Zhen Wang
    Yan-Jiang Han
    Shun Huang
    Meng Wang
    Wen-Lan Zhou
    Hong-Sheng Li
    Quan-Shi Wang
    Hu-Bing Wu
    Amino Acids, 2018, 50 : 309 - 320
  • [24] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Li Wang
    Min Yao
    Liu-Hong Pan
    Qi Qian
    Deng-Fu Yao
    Hepatobiliary&PancreaticDiseasesInternational, 2015, 14 (04) : 361 - 366
  • [25] Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular Carcinoma
    Jorge Filmus
    Mariana Capurro
    Molecular Diagnosis, 2004, 8 (4) : 207 - 212
  • [26] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Wang, Li
    Yao, Min
    Pan, Liu-Hong
    Qian, Qi
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (04) : 361 - 366
  • [27] Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas
    Wang, Xiao Ying
    Degos, Francoise
    Dubois, Sylvie
    Tessiore, Sandrine
    Allegretta, Mark
    Guttmann, Ronald D.
    Jothy, Serge
    Belghiti, Jacques
    Bedossa, Pierre
    Paradis, Valerie
    HUMAN PATHOLOGY, 2006, 37 (11) : 1435 - 1441
  • [28] Identification of microRNAs controlling Glypican-3 expression in hepatocellular carcinoma
    Maurel, M.
    Ladeiro, Y.
    Jalvy-Delvaille, S.
    Pitard, V.
    Vachet, L.
    Combe, C.
    Sagliocco, F.
    Zucman-Rossi, I.
    Laloo, B.
    Grosset, C.
    BULLETIN DU CANCER, 2011, 98 : S43 - S44
  • [29] Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma
    Lin, Fanching
    Clift, Renee
    Ehara, Takeru
    Yanagida, Hayato
    Horton, Steven
    Noncovich, Alain
    Guest, Matt
    Kim, Daniel
    Salvador, Katrina
    Richardson, Samantha
    Miller, Terra
    Han, Guangzhou
    Bhat, Abhijit
    Song, Kenneth
    Li, Gary
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (04) : 586 - 592
  • [30] GLUTAMINE SYNTHETASE,GLYPICAN-3 AND ARGINSASE-1 EXPRESSION IN THE DIFFERENTIAL DIAGNOSIS OF HEPATOCELLULAR CARCINOMA VS.METASTATIC CARCINOMAS OF THE LIVER
    Argon, A.
    Erbil, S.
    Nart, D.
    Yilmaz, F.
    WORLD CANCER RESEARCH JOURNAL, 2019, 6
12345